Accent Microcell Limited (NSE:ACCENTMIC)
319.00
-19.85 (-5.86%)
Jan 23, 2026, 3:29 PM IST
Accent Microcell Revenue
Accent Microcell had revenue of 1.39B INR in the half year ending September 30, 2025, with 27.51% growth. This brings the company's revenue in the last twelve months to 2.78B, up 5.99% year-over-year. In the fiscal year ending March 31, 2025, Accent Microcell had annual revenue of 2.65B with 7.84% growth.
Revenue (ttm)
2.78B
Revenue Growth
+5.99%
P/S Ratio
2.44
Revenue / Employee
14.49M
Employees
192
Market Cap
6.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.65B | 192.53M | 7.84% |
| Mar 31, 2024 | 2.46B | 483.37M | 24.50% |
| Mar 31, 2023 | 1.97B | 315.51M | 19.04% |
| Mar 31, 2022 | 1.66B | 322.98M | 24.21% |
| Mar 31, 2021 | 1.33B | 19.39M | 1.47% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.30B |
| Venus Remedies | 6.99B |
| Lincoln Pharmaceuticals | 6.32B |
| Wanbury | 6.31B |
| Sudarshan Pharma Industries | 5.92B |
| Kopran | 5.92B |
| Fermenta Biotech | 5.63B |
| Fredun Pharmaceuticals | 5.31B |